| Accession Number | 0002050035-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Head of US Oncology | Common Stock | โ | Jan 6, 2026 | Tax Withholding | 8,264 | $106.66 | $881,438.24 | 76,988 | Direct | โ | View Details | |
EVP, Head of US Oncology | Common Stock | โ | Jan 7, 2026 | Sale | 10,856 | $109.07 | $1,184,063.92 | 66,132 | Direct | โ | View Details |